Literature DB >> 21889435

Ribosomal protein metallopanstimulin-1 impairs multiple myeloma CAG cells growth and inhibits fibroblast growth factor receptor 3.

Yuemeng Dai1, Spencer Pierson, Cross Dudney, Yuxin Zeng, Veronica Macleod, John D Shaughnessy, Brendan C Stack.   

Abstract

INTRODUCTION: It was demonstrated that metallopanstimulin-1 (MPS-1, RPS27) inhibited the growth of tumors formed by head and neck squamous cell carcinoma cells and reduced paxillin gene expression.
METHODS: The present study examined whether and how MPS-1 affects another type of cancer, multiple myeloma (CAG). Enhanced expression of MPS-1 dramatically inhibited CAG in vitro and in vivo.
RESULTS: Overexpression of MPS-1 resulted in decreased fibroblast growth factor (FGF2) receptor 3 and impaired endogenous MAPK/ErK signaling. MAPK/ErK signaling was not stimulated by adding recombinant FGF2 to myeloma cells overexpressing MPS-1.
CONCLUSIONS: These data suggest that MPS-1 suppresses CAG growth and that weakened FGF2 signaling may contribute to this effect.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21889435      PMCID: PMC3384726          DOI: 10.1016/j.clml.2011.06.015

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


  20 in total

1.  Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells.

Authors:  Fenghuang Zhan; Johanna Hardin; Bob Kordsmeier; Klaus Bumm; Mingzhong Zheng; Erming Tian; Ralph Sanderson; Yang Yang; Carla Wilson; Maurizio Zangari; Elias Anaissie; Christopher Morris; Firas Muwalla; Frits van Rhee; Athanasios Fassas; John Crowley; Guido Tricot; Bart Barlogie; John Shaughnessy
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

2.  Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma.

Authors:  M Chesi; L A Brents; S A Ely; C Bais; D F Robbiani; E A Mesri; W M Kuehl; P L Bergsagel
Journal:  Blood       Date:  2001-02-01       Impact factor: 22.113

3.  The myeloma-associated oncogene fibroblast growth factor receptor 3 is transforming in hematopoietic cells.

Authors:  Z Li; Y X Zhu; E E Plowright; P L Bergsagel; M Chesi; B Patterson; T S Hawley; R G Hawley; A K Stewart
Journal:  Blood       Date:  2001-04-15       Impact factor: 22.113

4.  S29 ribosomal protein induces apoptosis in H520 cells and sensitizes them to chemotherapy.

Authors:  Neeru Khanna; Sudip Sen; Himani Sharma; Neeta Singh
Journal:  Biochem Biophys Res Commun       Date:  2003-04-25       Impact factor: 3.575

5.  Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparin-binding proteins.

Authors:  M Børset; O Hjertner; S Yaccoby; J Epstein; R D Sanderson
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

Review 6.  Nuclear actin and actin-related proteins in chromatin remodeling.

Authors:  Ivan A Olave; Samara L Reck-Peterson; Gerald R Crabtree
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

7.  Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice.

Authors:  Jing Qing; Xiangnan Du; Yongmei Chen; Pamela Chan; Hao Li; Ping Wu; Scot Marsters; Scott Stawicki; Janet Tien; Klara Totpal; Sarajane Ross; Susanna Stinson; David Dornan; Dorothy French; Qian-Rena Wang; Jean-Philippe Stephan; Yan Wu; Christian Wiesmann; Avi Ashkenazi
Journal:  J Clin Invest       Date:  2009-04-20       Impact factor: 14.808

8.  Extraribosomal function of metallopanstimulin-1: reducing paxillin in head and neck squamous cell carcinoma and inhibiting tumor growth.

Authors:  Yuemeng Dai; Spencer E Pierson; W Cross Dudney; Brendan C Stack
Journal:  Int J Cancer       Date:  2010-02-01       Impact factor: 7.396

9.  Gene transfer improves erythroid development in ribosomal protein S19-deficient Diamond-Blackfan anemia.

Authors:  Isao Hamaguchi; Andreas Ooka; Ann Brun; Johan Richter; Niklas Dahl; Stefan Karlsson
Journal:  Blood       Date:  2002-10-15       Impact factor: 22.113

10.  Identification of RPS14 as a 5q- syndrome gene by RNA interference screen.

Authors:  Benjamin L Ebert; Jennifer Pretz; Jocelyn Bosco; Cindy Y Chang; Pablo Tamayo; Naomi Galili; Azra Raza; David E Root; Eyal Attar; Steven R Ellis; Todd R Golub
Journal:  Nature       Date:  2008-01-17       Impact factor: 49.962

View more
  3 in total

Review 1.  Ribosomal proteins: functions beyond the ribosome.

Authors:  Xiang Zhou; Wen-Juan Liao; Jun-Ming Liao; Peng Liao; Hua Lu
Journal:  J Mol Cell Biol       Date:  2015-03-03       Impact factor: 6.216

2.  Ribosomal Protein S27/Metallopanstimulin-1 (RPS27) in Glioma-A New Disease Biomarker?

Authors:  Jonas Feldheim; Almuth F Kessler; Dominik Schmitt; Ellaine Salvador; Camelia M Monoranu; Julia J Feldheim; Ralf-Ingo Ernestus; Mario Löhr; Carsten Hagemann
Journal:  Cancers (Basel)       Date:  2020-04-27       Impact factor: 6.639

3.  Overexpressed MPS-1 contributes to endometrioma development through the NF-κB signaling pathway.

Authors:  Jun Lin; Xiaohua Liu; Yang Liu; Junyan Ma; Liqi Zhang
Journal:  Reprod Biol Endocrinol       Date:  2021-07-15       Impact factor: 5.211

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.